Ross Pearlman
MOHS-Micrographic Surgery · Chicago, ILNPI 1144726555
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Sanofi at 57.4% of the total. 2025 is the largest year on record at $4,640, more than ten times the $376 reported in 2021.
Across 99 payments — averaging $78.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- Lilly USA, LLC$900
- AbbVie$612
- Johnson & Johnson$321
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$229
- Organogenesis Inc.$207
- plus $1K from 17 others
What the payments were for
- Consulting fees$3,68047%
- Travel & lodging$3024%
- Food & beverage$3,78449%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 8 | $4,457 |
| Lilly USA, LLC | 28 | $900 |
| AbbVie | 13 | $612 |
| Johnson & Johnson | 14 | $321 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $229 |
| Organogenesis Inc. | 4 | $207 |
| Regeneron Healthcare Solutions, Inc. | 4 | $141 |
| Boehringer Ingelheim | 1 | $125 |
| Merz North America, Inc. | 1 | $116 |
| Incyte Corporation | 2 | $88 |
| E.r. Squibb & Sons, L.L.C. | 2 | $84 |
| UCB, Inc. | 2 | $68 |
| LEO Pharma Inc. | 3 | $60 |
| Pfizer | 3 | $50 |
| Smith+Nephew | 1 | $49 |
| Amgen | 1 | $48 |
| Arcutis Biotherapeutics, Inc. | 1 | $42 |
| Galderma Laboratories, L.p. | 2 | $39 |
| Mimedx Group, Inc. | 1 | $39 |
| Dermavant Sciences, Inc. | 1 | $27 |
| Almirall LLC | 1 | $26 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,766 in reported general payments places this provider in the 75th percentile of 40 mohs-micrographic surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 22 | $732 |
| Doxycycline Hyclate | 30 | $234 |
| Cephalexin | 36 | $134 |
| Mupirocin | 13 | $88 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Chicago
- Todd JohnsonChicago$10K
- Simon YooChicago$10K
- Daniel SchlessingerChicago$8K
- Aleksandar KrunicChicago$8K
- Sarah WilsonChicago$8K
- Maxim PolanskyChicago$4K
- Nour El-KashlanChicago$3K
- Neda AshourianChicago$2K
- Jean Christophe LapiereChicago$1K
- Murad AlamChicago$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.